Innate Pharma SA (IPHA) said Monday it has appointed Jonathan Dickinson as chief executive officer and chairman of the executive board, effective Nov. 1, replacing Herve Brailly.
Dickinson most recently served as executive vice president and general manager for Europe at Incyte (INCY).
Brailly, who served as interim CEO, will stay in an advisory role during the transition process, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.